Literature DB >> 24785975

Combined effect of hyperuricemia and overweight/obesity on the prevalence of hypertension among US adults: result from the National Health and Nutrition Examination Survey.

G-M Han1, S Gonzalez2, D DeVries3.   

Abstract

Hypertension is a large and growing public health problem worldwide. Hyperuricemia and overweight/obesity are two of the most important risk factors for hypertension. However, their combined effect on the risk of hypertension is not known. Participants aged 20 years and older from the National Health and Nutrition Examination Survey from 1999-2012 were used to evaluate the separate and combined effects of hyperuricemia and overweight/obesity on the risk of prevalent hypertension among different race, gender and age groups. Participants (31,473) were used to estimate separate and combined effects on the prevalence of hypertension. The overall prevalence of hypertension among adults with a combination of hyperuricemia and overweight/obesity (50.2%, 95% confidence interval (CI) 48.3-52.1%) was significantly higher than separate hyperuricemia (41.7%, 95% CI 37.2-46.2%) and overweight/obesity (30.6%, 95% CI 29.5-31.8%). The magnitude of odds ratio (OR) from the combination of hyperuricemia and overweight/obesity (OR=4.53, 95% CI 4.05-5.07) was significantly higher than both hyperuricemia (OR=2.62, 95% CI 2.07-3.32) and overweight/obesity (OR=2.08, 95% CI 1.89-2.30). Combined effect of hyperuricemia and overweight/obesity on the risk of hypertension is much stronger than any separate one. These data can provide important information for identification of target populations for future intervention and patient management.

Entities:  

Mesh:

Year:  2014        PMID: 24785975     DOI: 10.1038/jhh.2014.31

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  34 in total

1.  Obesity-related hypertension?: weighing the evidence.

Authors:  Theodore A Kotchen
Journal:  Hypertension       Date:  2008-10-13       Impact factor: 10.190

2.  Global burden of hypertension: analysis of worldwide data.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

3.  Serum uric acid in relation to body weight.

Authors:  V Krízek
Journal:  Ann Rheum Dis       Date:  1966-09       Impact factor: 19.103

4.  An abnormal sodium metabolism in Japanese patients with essential hypertension, judged by serum sodium distribution, renal function and the renin-aldosterone system.

Authors:  I Komiya; T Yamada; N Takasu; T Asawa; H Akamine; N Yagi; Y Nagasawa; H Ohtsuka; Y Miyahara; H Sakai; A Sato; T Aizawa
Journal:  J Hypertens       Date:  1997-01       Impact factor: 4.844

5.  Relationship of obesity to serum triglyceride, cholesterol, and uric acid, and to plasma-glucose levels.

Authors:  L E Hollister; J E Overall; H L Snow
Journal:  Am J Clin Nutr       Date:  1967-07       Impact factor: 7.045

6.  Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism.

Authors:  Marilda Mazzali; John Kanellis; Lin Han; Lili Feng; Yi-Yang Xia; Qiang Chen; Duk-Hee Kang; Katherine L Gordon; Susumu Watanabe; Takahiko Nakagawa; Hui Y Lan; Richard J Johnson
Journal:  Am J Physiol Renal Physiol       Date:  2002-06

7.  Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence.

Authors:  Johan Sundström; Lisa Sullivan; Ralph B D'Agostino; Daniel Levy; William B Kannel; Ramachandran S Vasan
Journal:  Hypertension       Date:  2004-11-29       Impact factor: 10.190

8.  Association of uric acid with obesity and endothelial dysfunction in children and early adolescents.

Authors:  Manabu Ishiro; Ryuzo Takaya; Yasuhiko Mori; Kimitaka Takitani; Yukako Kono; Keisuke Okasora; Toshihiko Kasahara; Hiroshi Tamai
Journal:  Ann Nutr Metab       Date:  2013-02-22       Impact factor: 3.374

9.  Uric acid best predicts metabolically unhealthy obesity with increased cardiovascular risk in youth and adults.

Authors:  Harald Mangge; Sieglinde Zelzer; Peter Puerstner; Wolfgang J Schnedl; Gloria Reeves; Teodor T Postolache; Daniel Weghuber
Journal:  Obesity (Silver Spring)       Date:  2013-01-29       Impact factor: 5.002

Review 10.  Sodium and potassium and the pathogenesis of hypertension.

Authors:  Katarzyna Stolarz-Skrzypek; Adam Bednarski; Danuta Czarnecka; Kalina Kawecka-Jaszcz; Jan A Staessen
Journal:  Curr Hypertens Rep       Date:  2013-04       Impact factor: 5.369

View more
  4 in total

1.  Ribose Accelerates Gut Motility and Suppresses Mouse Body Weight Gaining.

Authors:  Yan Liu; Tong-Ruei R Li; Cong Xu; Tian Xu
Journal:  Int J Biol Sci       Date:  2016-04-28       Impact factor: 6.580

2.  Effect of a Modest Weight Loss in Normalizing Blood Pressure in Obese Subjects on Antihypertensive Drugs.

Authors:  Luisa Gilardini; Gabriella Redaelli; Marina Croci; Antonio Conti; Lucia Pasqualinotto; Cecilia Invitti
Journal:  Obes Facts       Date:  2016-07-26       Impact factor: 3.942

3.  Excess serum uric acid is associated with metabolic syndrome in obese adolescent patients.

Authors:  Christy Foster; Loretta Smith; Ramin Alemzadeh
Journal:  J Diabetes Metab Disord       Date:  2020-05-16

4.  Does obesity modify the epidemiological association between hyperuricemia and the prevalence of hypertension among Northern Chinese community-dwelling people? A Chinese population-based study.

Authors:  Simiao Tian; Yazhuo Liu; Yang Xu; Ao Feng
Journal:  BMJ Open       Date:  2019-11-21       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.